Literature DB >> 27447112

Intrinsic aggregation propensity of the p63 and p73 TI domains correlates with p53R175H interaction and suggests further significance of aggregation events in the p53 family.

Sebastian Kehrloesser1, Christian Osterburg1, Marcel Tuppi1, Birgit Schäfer1, Karen Heather Vousden2, Volker Dötsch1.   

Abstract

The high percentage of p53 missense mutations found in cancer has been attributed to mutant acquired oncogenic gain of functions. Different aspects of these tumour-promoting functions are caused by repression of the transcriptional activity of p53 family members p63 and p73. A subset of frequently occurring p53 mutations results in thermodynamic destabilisation of the DNA-binding domain (DBD) rendering this domain highly unstable. These conformational mutants (such as p53R175H) have been suggested to directly bind to p63 and p73 via a co-aggregation mechanism mediated by their DBDs. Although the DBDs of p63 and p73 are in fact not sufficient for the interaction as shown previously, we demonstrate here that the transactivation inhibitory (TI) domains within the α-isoform-specific C termini of p63 and p73 are essential for binding to p53R175H. Hence, the closed dimeric conformation of inactive TAp63α that renders the TI domain inaccessible prevents efficient interaction. We further show that binding to p53R175H correlates with an intrinsic aggregation propensity of the tetrameric α-isoforms conferred by an openly accessible TI domain again supporting interaction via a co-aggregation mechanism.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27447112      PMCID: PMC5136486          DOI: 10.1038/cdd.2016.75

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  60 in total

1.  Solution structure of a conserved C-terminal domain of p73 with structural homology to the SAM domain.

Authors:  S W Chi; A Ayed; C H Arrowsmith
Journal:  EMBO J       Date:  1999-08-16       Impact factor: 11.598

2.  Structural evolution of p53, p63, and p73: implication for heterotetramer formation.

Authors:  Andreas C Joerger; Sridharan Rajagopalan; Eviatar Natan; Dmitry B Veprintsev; Carol V Robinson; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

3.  Gain of function of mutant p53 by coaggregation with multiple tumor suppressors.

Authors:  Jie Xu; Joke Reumers; José R Couceiro; Frederik De Smet; Rodrigo Gallardo; Stanislav Rudyak; Ann Cornelis; Jef Rozenski; Aleksandra Zwolinska; Jean-Christophe Marine; Diether Lambrechts; Young-Ah Suh; Frederic Rousseau; Joost Schymkowitz
Journal:  Nat Chem Biol       Date:  2011-03-27       Impact factor: 15.040

Review 4.  Mutant p53 gain-of-function in cancer.

Authors:  Moshe Oren; Varda Rotter
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

5.  Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinoma.

Authors:  Matthew R Ramsey; Lei He; Nicole Forster; Benjamin Ory; Leif W Ellisen
Journal:  Cancer Res       Date:  2011-04-28       Impact factor: 12.701

6.  p73 suppresses polyploidy and aneuploidy in the absence of functional p53.

Authors:  Flaminia Talos; Alice Nemajerova; Elsa R Flores; Oleksi Petrenko; Ute M Moll
Journal:  Mol Cell       Date:  2007-08-17       Impact factor: 17.970

7.  Spectrum of p63 mutations in a selected patient cohort affected with ankyloblepharon-ectodermal defects-cleft lip/palate syndrome (AEC).

Authors:  Tuula Rinne; Emine Bolat; Rowdy Meijer; Hans Scheffer; Hans van Bokhoven
Journal:  Am J Med Genet A       Date:  2009-09       Impact factor: 2.802

8.  Interaction of p53 with the CCT complex promotes protein folding and wild-type p53 activity.

Authors:  Antonio Garcia Trinidad; Patricia A J Muller; Jorge Cuellar; Marta Klejnot; Max Nobis; José María Valpuesta; Karen H Vousden
Journal:  Mol Cell       Date:  2013-06-06       Impact factor: 17.970

9.  Structure and kinetic stability of the p63 tetramerization domain.

Authors:  Eviatar Natan; Andreas C Joerger
Journal:  J Mol Biol       Date:  2011-11-12       Impact factor: 5.469

10.  Conservation of DNA-binding specificity and oligomerisation properties within the p53 family.

Authors:  Tobias Brandt; Miriana Petrovich; Andreas C Joerger; Dmitry B Veprintsev
Journal:  BMC Genomics       Date:  2009-12-23       Impact factor: 3.969

View more
  27 in total

1.  Sustained protein synthesis and reduced eEF2K levels in TAp73-\- mice brain: a possible compensatory mechanism.

Authors:  Barak Rotblat; Massimiliano Agostini; Maria Victoria Niklison-Chirou; Ivano Amelio; Anne E Willis; Gerry Melino
Journal:  Cell Cycle       Date:  2018-12-04       Impact factor: 4.534

2.  Sulfated glycosaminoglycans mediate prion-like behavior of p53 aggregates.

Authors:  Naoyuki Iwahashi; Midori Ikezaki; Taro Nishikawa; Norihiro Namba; Takashi Ohgita; Hiroyuki Saito; Yoshito Ihara; Toshinori Shimanouchi; Kazuhiko Ino; Kenji Uchimura; Kazuchika Nishitsuji
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-14       Impact factor: 11.205

Review 3.  Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine.

Authors:  Michele Carbone; Ivano Amelio; El Bachir Affar; James Brugarolas; Lisa A Cannon-Albright; Lewis C Cantley; Webster K Cavenee; Zhijian Chen; Carlo M Croce; Alan D' Andrea; David Gandara; Carlotta Giorgi; Wei Jia; Qing Lan; Tak Wah Mak; James L Manley; Katsuhiko Mikoshiba; Jose N Onuchic; Harvey I Pass; Paolo Pinton; Carol Prives; Nathaniel Rothman; Said M Sebti; James Turkson; Xifeng Wu; Haining Yang; Herbert Yu; Gerry Melino
Journal:  Cell Death Differ       Date:  2018-10-15       Impact factor: 15.828

4.  Designed Ankyrin Repeat Proteins as a tool box for analyzing p63.

Authors:  Alexander Strubel; Philipp Münick; Apirat Chaikuad; Birgit Dreier; Jonas Schaefer; Jakob Gebel; Christian Osterburg; Marcel Tuppi; Birgit Schäfer; Stefan Knapp; Andreas Plückthun; Volker Dötsch
Journal:  Cell Death Differ       Date:  2022-06-18       Impact factor: 15.828

5.  Heterotypic Amyloid β interactions facilitate amyloid assembly and modify amyloid structure.

Authors:  Katerina Konstantoulea; Patricia Guerreiro; Meine Ramakers; Nikolaos Louros; Liam D Aubrey; Bert Houben; Emiel Michiels; Matthias De Vleeschouwer; Yulia Lampi; Luís F Ribeiro; Joris de Wit; Wei-Feng Xue; Joost Schymkowitz; Frederic Rousseau
Journal:  EMBO J       Date:  2021-11-29       Impact factor: 11.598

6.  p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cells.

Authors:  Luciana P Rangel; Giulia D S Ferretti; Caroline L Costa; Sarah M M V Andrade; Renato S Carvalho; Danielly C F Costa; Jerson L Silva
Journal:  J Biol Chem       Date:  2019-01-02       Impact factor: 5.157

7.  Mutant and wild-type p53 form complexes with p73 upon phosphorylation by the kinase JNK.

Authors:  Eric R Wolf; Ciarán P McAtarsney; Kristin E Bredhold; Amber M Kline; Lindsey D Mayo
Journal:  Sci Signal       Date:  2018-04-03       Impact factor: 8.192

8.  Integrin-β4 is a novel transcriptional target of TAp73.

Authors:  Ningxia Xie; Polina Vikhreva; Margherita Annicchiarico-Petruzzelli; Ivano Amelio; Nicolai Barlev; Richard A Knight; Gerry Melino
Journal:  Cell Cycle       Date:  2018-02-08       Impact factor: 4.534

9.  Multisite aggregation of p53 and implications for drug rescue.

Authors:  GuoZhen Wang; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-14       Impact factor: 11.205

10.  p73 Regulates Primary Cortical Neuron Metabolism: a Global Metabolic Profile.

Authors:  Massimiliano Agostini; Maria Victoria Niklison-Chirou; Margherita Maria Annicchiarico-Petruzzelli; Sandro Grelli; Nicola Di Daniele; Ilias Pestlikis; Richard A Knight; Gerry Melino; Alessandro Rufini
Journal:  Mol Neurobiol       Date:  2017-05-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.